dynaCERT Announces Warrant Amendments
February 04, 2019 16:30 ET
|
dynaCERT Inc.
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received approval from the...
dynaCERT Launches HydraGEN™ Technology for the Mining Industry
February 04, 2019 07:00 ET
|
dynaCERT Inc.
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a new order for its...
dynaCERT Continues Innovation and Development of Intellectual Property Globally
January 31, 2019 08:30 ET
|
dynaCERT Inc.
TORONTO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide an update on its numerous patents relating...
dynaCERT Appoints Mr. Frank Klees, Former Ontario Cabinet Minister, to Advisory Board
January 24, 2019 08:30 ET
|
dynaCERT Inc.
TORONTO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the appointment of Mr. Frank Klees to the...
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
December 19, 2018 08:06 ET
|
Small Logo
LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...
Emerald Health Therapeutics Receives TSX Venture Conditional Approval of Emerald Health Naturals Joint Venture
November 19, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald...
dynaCERT Offers a Solution to 2019 European CO2 Regulations
September 24, 2018 09:19 ET
|
dynaCERT Inc.
TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide an update on the TUV and homologation...
Galaxy Gaming Receives Key Approval in the State of Ohio
February 27, 2018 14:29 ET
|
Galaxy Gaming, Inc.
LAS VEGAS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC:GLXZ), Galaxy Gaming is pleased to announce that it has received approval from the Ohio Casino Control Commission by a unanimous...
Jubilant DraxImage receives approval for new pulmonary indications from the
U.S. Food and Drug Administration for DRAXIMAGE® DTPA
January 02, 2018 10:45 ET
|
Jubilant DraxImage
Montreal, QC, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma wholly-owned subsidiary, is pleased to announce approval of new pulmonary indications for...
Jubilant DraxImage receives approval for 12-Hour shelf-life extension from the U.S. Food and Drug Administration for DRAXIMAGE® MAA
October 31, 2017 08:45 ET
|
Jubilant DraxImage
Montreal, QC, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a wholly-owned subsidiary of Jubilant Pharma, is pleased to announce the U.S. Food and Drug Administration...